MTLS — MATERIALISE NV (Technology >> Software - Application)
MTLS FAQ
What is MTLS's P/E ratio?
MATERIALISE NV (MTLS) currently trades at a P/E ratio of 38.62.
What is MTLS's ROE?
MATERIALISE NV reports a Return on Equity (ROE) of 4.07%.
What is MTLS's dividend yield?
MATERIALISE NV offers a dividend yield of 0.00%.
What is MTLS's Deepscope Quality Score?
Deepscope rates MTLS's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy MTLS?
Deepscope's AI Timing Score for MTLS is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does MTLS belong to?
MATERIALISE NV is classified under the Technology >> Software - Application sector on the NASDAQ exchange.
|
USD 6.61
Price
-0.28
(-4.06%)
Day Change
|
|
|---|
MTLS, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 81 |
| Magic Formula Rank by ROA |
2778
|
| Magic Formula Rank by ROE |
2778
|
| Magic Formula Rank by ROIC |
2906
|
| Price | 6.61 |
| PBV / Sector |
1.57 / 88.89
GOOD
|
| Earning Per Share | 0.17 |
| PE / Sector |
38.62 / 29.18
|
| PEG or PE/Growth / Sector |
-0.32 / 0.22
|
| Average 1M Daily Value |
1.00 M
GREAT
|
| Average 1W Daily Value |
1.40 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
58% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-04 09:24:17 |
| Symbol | MTLS |
| Name | MATERIALISE NV |
| Sector | Technology >> Software - Application |
| Market | NASDAQ |
| Listed Shares | 58.26 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 401.40 / 16,577.51 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Technologielaan 15, Leuven, Belgium, 3001
Phone: 32 1 639 66 11
Website: https://www.materialise.com
Employees: 2,556
Description: Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
ME vs SECTOR Technology >> Software - Application
Click a bubble to view stock details · Bubble size represents market capitalization share
Google